The investment seeks total return consistent with income generation. The fund seeks to achieve its objective through investments in income-producing securities issued by entities deemed by the Adviser ...
The investment seeks total return consistent with income generation. The fund seeks to achieve its objective through investments in income-producing securities issued by entities deemed by the Adviser ...
Fintel reports that on November 7, 2025, Truist Securities maintained coverage of Collegium Pharmaceutical (NasdaqGS:COLL) with a Buy recommendation. Analyst Price Forecast Suggests 11.88% Upside As ...
Fintel reports that on November 7, 2025, Truist Securities maintained coverage of Collegium Pharmaceutical (NasdaqGS:COLL) with a Buy recommendation. As of October 30, 2025, the average one-year price ...
Fintel reports that on October 28, 2025, Needham reiterated coverage of Collegium Pharmaceutical (NasdaqGS:COLL) with a Buy recommendation. Analyst Price Forecast Suggests 30.67% Upside As of ...
Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Fund summary The fund seeks to achieve its objective through investments in income-producing securities issued by entities deemed by the Adviser to be serving well the needs of customers, employees, ...
BOSTON, Sept. 3, 2020 /PRNewswire/ -- Eventide is pleased to announce the launch of its seventh mutual fund, the Eventide Core Bond Fund (ETARX, ETCRX, ETNRX, ETIRX). With a primary objective of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback